New tissue atlas aims to help AI understand cancer

How cells are arranged within tissue can reveal as much about disease as the cells themselves. When doctors examine a cancer tumor, for example, they don't just look at which cells are present. The science-journalism coverage adds useful context, while the strongest evidential footing still comes from the underlying data, papers or institutional documentation.

It is relevant because biology becomes more informative when an observed effect begins to look like a mechanism rather than an isolated pattern. The gap between identifying a correlation in biological data and understanding the causal chain that produces it is routinely underestimated, and the history of biomedical research is populated with associations that collapsed when the mechanism was sought and not found. A result that comes with a proposed mechanism, even a partial one, is more useful than a purely descriptive finding because it generates testable predictions that can narrow the hypothesis space. By Tanya Petersen, Ecole Polytechnique Federale de Lausanne This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility: Add to Preferred Sources Imaging mass cytometry of a lung tumor core from a tissue.

2026 EPFL/AIMM, CC-BY-SA 4.0 How cells are arranged within tissue can reveal as much about disease as the cells themselves. Research laboratories around the world use different equipment, examine different proteins and store their results in different ways.

Released in collaboration with the European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI), the collection includes 13, 546 multiplex images from 5, 477. Creating spora took two years of work by scientists and biomedical experts from EPFL, University Hospital Zurich, the University of Zurich, Geneva University Hospitals and the.

The researchers had to organize thousands of images, standardize protein annotations, match medical information and identify individual cells so that data from different studies. Gathering and harmonizing data across cohorts takes enormous time, creating a major hurdle for both large-scale AI development and biological discovery," says Benedikt von.

The broader interest lies in whether the reported effect points toward a real mechanism and not merely a reproducible but unexplained association. Biology has learned from decades of biomarker failures that correlation, even robust correlation, is not a substitute for mechanistic understanding. A pathway that can be traced from molecular interaction to cellular response to organismal phenotype provides a far stronger foundation for intervention than a statistical association discovered in a large dataset, however well the statistics are done.

We want to allow researchers to start with ready-to-use data so that they can focus on the models and biological questions. Differences in the proteins measured, imaging conditions and available clinical information remain visible, helping researchers decide which data sets are appropriate for their.

Because this item comes through Phys. org Biology as science journalism, it should be treated as contextual reporting rather than primary evidence. Good science reporting can identify why a result matters, connect it to the wider literature and make technical work readable, but the decisive evidence remains in the original paper, dataset, mission release or technical record. That distinction is especially important when a story is later repeated by aggregators, because repetition increases visibility, not evidential strength.

The next step is to test whether the effect repeats across different methods, cell types, model organisms and experimental conditions. Reproducibility is the first test, but mechanistic dissection is the second, and a result that passes both has a substantially better chance of translating into something clinically or biotechnologically useful. The path from a laboratory finding to an applied outcome typically takes a decade or more, and most findings do not complete it; the current result sits at the beginning of that process.

Source